Study title: Phase II single-centre, randomised, open study comparing 20 treated patients versus 20 historical non treated patients with Rett Syndrome (RS)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Nervous System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: ACETYL-L-CARNITINE | |||||
ATC code: N06BX12 | |||||
Document link: ST200 DS 2001 002 linelisting2011.xls | |||||
Document date: 2011-09-15 | |||||
Study number: ST200 DS 2001 002 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |